Compass Therapeutics CMPX Insider Ownership

NASDAQ CMPX
$2.40 +0.04 (+1.48%)
As of: Sep 4, 2026 · 11:47 AM EDT

Insider Holdings by Owner

10.85Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
1.85%
0% pp QoQ
Shares Held by Insiders
3.12Mn
filed for Sep 2026
0.00% QoQ
Shares Outstanding
168.78Mn
168,782,000 shares
Direct Holdings
3.12Mn
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
5
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of August 29, 2026, the three largest insider holders of CMPX are Thomas J. Schuetz (Chief Executive Officer, 6.60Mn shares), Thomas J. Schuetz (Chief Executive Officer, 6.60Mn shares), Vered Bisker-Leib (Chief Executive Officer, 3.12Mn shares).

Form 4 Holdings

Insiders Holding CMPX

Insiders 5
Shares held 10.85Mn
Of outstanding 6.43%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Thomas J. Schuetz Chief Executive Officer 6,603,336 0 6,603,336 60.9% 10 Feb, 2026
2 Vered Bisker-Leib Chief Executive Officer 3,124,426 0 3,124,426 28.8% 09 Feb, 2024
3 Barry Shin Cfo 525,000 0 525,000 4.8% 05 Jan, 2026
4 Neil Lerner Chief Accounting Officer 397,500 0 397,500 3.7% 30 Apr, 2026
5 Jonathan Anderman General Counsel 196,000 0 196,000 1.8% 30 Apr, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

289 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
29 Apr, 2026 Jonathan Anderman General Counsel Acquired P 25,000 $1.89 $47.25K 196,000 Direct
29 Apr, 2026 Neil Lerner Chief Accounting Officer Acquired P 15,000 $1.89 $28.35K 397,500 Direct
29 Apr, 2026 Jonathan Anderman General Counsel Acquired A 25,000 $1.89 $47.25K 196,000 Direct
29 Apr, 2026 Neil Lerner Chief Accounting Officer Acquired A 15,000 $1.89 $28.35K 397,500 Direct
08 Feb, 2026 Thomas J. Schuetz Chief Executive Officer Disposed F 36,687 $6.52 $239.20K 6,603,336 Direct
08 Feb, 2026 Thomas J. Schuetz Chief Executive Officer Disposed F 36,687 $6.52 $239.20K 6,603,336 Direct
08 Feb, 2026 Thomas J. Schuetz Chief Executive Officer Disposed F 36,687 $6.52 $239.20K 6,603,336 Direct
08 Feb, 2026 Thomas J. Schuetz Chief Executive Officer Disposed F 36,687 $6.52 $239.20K 6,603,336 Direct
09 Jan, 2026 Thomas J. Schuetz Chief Executive Officer Disposed F 46,777 $5.35 $250.26K 6,640,023 Direct
09 Jan, 2026 Thomas J. Schuetz Chief Executive Officer Disposed F 46,777 $5.35 $250.26K 6,640,023 Direct
09 Jan, 2026 Thomas J. Schuetz Chief Executive Officer Disposed F 46,777 $5.35 $250.26K 6,640,023 Direct
09 Jan, 2026 Thomas J. Schuetz Chief Executive Officer Disposed F 46,777 $5.35 $250.26K 6,640,023 Direct
02 Jan, 2026 Arjun Prasad Chief Commercial Officer Acquired A 1,000,000 $0.00 $0 1,000,000 Direct
02 Jan, 2026 Thomas J. Schuetz Ceo Acquired A 250,000 $5.17 $1.29Mn 6,686,800 Direct
02 Jan, 2026 Thomas J. Schuetz Ceo Acquired A 250,000 $5.17 $1.29Mn 6,686,800 Direct
02 Jan, 2026 Cynthia Sirard Chief Medical Officer Acquired A 1,000,000 $0.00 $0 1,000,000 Direct
02 Jan, 2026 Richard S Lindahl Director Acquired A 90,000 $0.00 $0 90,000 Direct
02 Jan, 2026 Philip Ferneau Director Acquired A 90,000 $0.00 $0 90,000 Direct
02 Jan, 2026 Thomas J. Schuetz Ceo Acquired A 250,000 $5.17 $1.29Mn 6,686,800 Direct
02 Jan, 2026 Arjun Prasad Chief Commercial Officer Acquired A 1,000,000 $0.00 $0 1,000,000 Direct